UPPER LIMB BLOCK USING DEXMEDETOMIDINE.
Phase 4
Not yet recruiting
- Conditions
- Patients undergoing upper limb surgeries
- Registration Number
- CTRI/2013/04/003598
- Lead Sponsor
- Peoples Hospital
- Brief Summary
A Randomized double blind case control study :
GROUP C (n=30) receives 0.25% plain Bupivacaine + 0.3 ml Normal Saline total volume 30 ml. GROUP D (n=30) receives 0.25% Bupivacaine + 0.3 ml Dexmedetomidine (30µg) total volume 30 ml.
Through supraclavicular approach with the aid of a nerve stimulator, by using a 22 G short beveled, insulated 25mm stimulating needle.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
ASA 1 and ASA 2 patients posted for upper limb surgeries.
Exclusion Criteria
ASA 3 and ASA 4 patients Patients with neurological deficit Patients with history of seizures Patients with bleeding disorders Patients with pneumothorax Patient with pregnancy Uncooperative patient Patients refusal.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Onset of Sensory block Till the requirements of first analgesia Duration of Sensory block Till the requirements of first analgesia Onset of Motor block Till the requirements of first analgesia Demand of Analgesia Till the requirements of first analgesia Duration of Motor block Till the requirements of first analgesia Hemodynamic changes Till the requirements of first analgesia Any other adverse effects Till the requirements of first analgesia
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Peoples Hospital
🇮🇳Bhopal, MADHYA PRADESH, India
Peoples Hospital🇮🇳Bhopal, MADHYA PRADESH, IndiaDr Vaishali WaindeskarPrincipal investigator09575604490vaishaliwaind@gmail.com